Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DISC1 intronic transcript 1 (DISC1-IT1) is a long non-coding RNA transcribed from an intronic region at the DISC1 locus. While the protein-coding gene DISC1 (Disrupted in schizophrenia 1) plays a significant role in neurodevelopment, psychiatric disease risk, and gene regulation in the brain, DISC1-IT1 itself does not encode a protein but may regulate local chromatin structure or DISC1 gene expression. The DISC1 genomic region is subject to complex alternative splicing and intergenic fusions related to psychiatric illness, most notably schizophrenia[1][3]. There are no reports indicating that DISC1-IT1 is a direct therapeutic drug target, nor are there characterized small molecule or biological interactors. Its biological and disease role is mainly inferred from its genomic position and relation to the highly studied DISC1 locus[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DISC1 intronic transcript 1 (non-protein coding) (DISC1-IT1).